ANTH   $1e-06  -99.00% Market Closed

ANTHERA PHARMS INC NEW
Total Cash 8.09M
totalCashPerShare 0.309
EBITDA -36.40M
Total Debt 0.00
quickRatio 3.056
currentRatio 3.303
Total Revenue
debtToEquity
Revenue/Share
ROA -1.4196299
ROE -5.68847
grossProfits
freeCashflow -17.92M
operatingCashflow -31.95M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -8.08M
forwardPE
floatShares 26.13M
sharesOutstanding 26.18M
sharesShort 2.02M
sharesShortPriorMonth 1.43M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.0
heldPercentInstitutions 0.0
Short Ratio help_outline 2.09%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 0.209
Price To Book help_outline 0.00
earningsQuarterlyGrowth
netIncomeToCommon -24.93M
trailingEps -0.01%
forwardEps -1.54%
enterpriseToEbitda 0.22
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2018
institutionsCount 0
lastUpdated Nov. 7, 2024, 3:05 a.m.